Clinical and Laboratory Characteristics of 144 Patients with Mediterranean Spotted Fever
- 18 February 2003
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 22 (2) , 126-128
- https://doi.org/10.1007/s10096-002-0879-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Efficacy and Safety of Clarithromycin as Treatment for Mediterranean Spotted Fever in Children: A Randomized Controlled TrialClinical Infectious Diseases, 2001
- In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayersJournal of Antimicrobial Chemotherapy, 2000
- Mortality in Serologically Unconfirmed Mediterranean Spotted FeverThe Journal of Infectious Diseases, 2000
- [Mediterranean boutonneuse fever. Study of 246 cases].1991
- Comparative, Randomized Trial of One-Day Doxycycline Versus 10-Day Tetracycline Therapy for Mediterranean Spotted FeverThe Journal of Infectious Diseases, 1987
- Mediterranean Spotted Fever: Clinical, Laboratory and Epidemiological Features of 199 CasesThe American Journal of Tropical Medicine and Hygiene, 1986
- CLIMATIC FACTORS IN RESURGENCE OF MEDITERRANEAN SPOTTED FEVERThe Lancet, 1986
- Mediterranean Spotted Fever: A Cooperative Study of 227 CasesClinical Infectious Diseases, 1985
- [Malignant form of Mediterranean boutonneuse fever. 6 cases].1983
- RESURGENCE OF MEDITERRANEAN SPOTTED FEVER IN SPAINThe Lancet, 1982